Commonly reported side effects of daclizumab include: antibody development and hyperglycemia.  See below for a comprehensive list of adverse effects.
Applies to daclizumab: subcutaneous solution
In addition to its needed effects, some unwanted effects may be caused by daclizumab. In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking daclizumab:
Some of the side effects that can occur with daclizumab may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to daclizumab: intravenous solution, subcutaneous solution
Common (1% to 10%): Lymphadenopathy, lymphadenitis[Ref]
Very common (10% or more): Rash (i.e., erythematous rash, exfoliative rash, macular rash, maculopapular rash, papular rash, pruritic rash, rash, vesicular rash) (11%)Common (1% to 10%): Dermatitis (i.e., allergic dermatitis, atopic dermatitis, bullous dermatitis, dermatitis, exfoliative dermatitis, seborrheic dermatitis, eczema, allergic dermatitis), folliculitis, acne, psoriasis, erythema, pruritus, dry skin Uncommon (0.1% to 1%): Toxic skin eruption, eczema nummular[Ref]
Common (1% to 10%): Tonsillitis, diarrheaFrequency not reported: Colitis[Ref]
Common (1% to 10%): Anemia, lymphocyte count decreased[Ref]
Frequency not reported: Anaphylaxis[Ref]
Very common (10% or more): Nasopharyngitis (25%), upper respiratory tract infection (17%)Common (1% to 10%): Bronchitis, pneumonia, laryngitis, rhinitis[Ref]
Common (1% to 10%): Depression[Ref]
Common (1% to 10%): Oropharyngeal pain, pyrexia[Ref]
Common (1% to 10%): ALT increased, AST increased, liver function test abnormal, hepatic enzymes increased[Ref]
Common (1% to 10%): Influenza, viral infection[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum,  Inc. "Australian Product Information." O 0
3. "Product Information. Zinbryta (daclizumab)." AbbVie US LLC, North Chicago, IL. 
Not all side effects for daclizumab may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Bladder pain
blistering, crusting, irritation, itching, or reddening of the skin
bloody or cloudy urine
body aches or pain
cough or hoarseness
cracked, dry, or scaly skin
difficult, burning, or painful urination
difficulty with breathing
discouragement
ear congestion
feeling sad or empty
fever or chills
frequent urge to urinate
headache
irritability
lack of appetite
loss of interest or pleasure
loss of voice
lower back or side pain
nasal congestion
painful or difficult urination
rash
runny nose
sneezing
sore throat
swelling
swollen, painful, or tender lymph glands in the neck, armpit, or groin
trouble concentrating
trouble sleeping
unusual tiredness or weakness


Dark urine
general feeling of tiredness or weakness
itching skin
light-colored stools
persistent loss of appetite
red, scaling, or crusted skin
right upper quadrant tenderness
stomach pain, continuing
vomiting
yellow eyes or skin


Thoughts or attempts at killing oneself
watery or bloody diarrhea


Dizziness
fast heartbeat
hives or welts
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
tightness in the chest


Blemishes on the skin
pimples
seizures

